JP2014520764A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520764A5 JP2014520764A5 JP2014517444A JP2014517444A JP2014520764A5 JP 2014520764 A5 JP2014520764 A5 JP 2014520764A5 JP 2014517444 A JP2014517444 A JP 2014517444A JP 2014517444 A JP2014517444 A JP 2014517444A JP 2014520764 A5 JP2014520764 A5 JP 2014520764A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- interferon
- disease
- pharmaceutical composition
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU2011/0146 | 2011-07-01 | ||
| CU2011000146A CU23963B1 (es) | 2011-07-01 | 2011-07-01 | Composiciones farmacéuticas a partir de derivados de la c-ficocianina y combinaciones con interferones del tipo i para el tratamiento de enfermedades cerebrales isquémicas y neurodegenerativas |
| PCT/CU2012/000003 WO2013004203A1 (es) | 2011-07-01 | 2012-06-29 | Compuestos y combinaciones farmacéuticas para el tratamiento de enfermedades cerebrales isquemicas y neurodegenerativas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520764A JP2014520764A (ja) | 2014-08-25 |
| JP2014520764A5 true JP2014520764A5 (enExample) | 2015-08-20 |
| JP6023803B2 JP6023803B2 (ja) | 2016-11-09 |
Family
ID=46614264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517444A Expired - Fee Related JP6023803B2 (ja) | 2011-07-01 | 2012-06-29 | 神経変性及び虚血性脳疾患を処置するための化合物及び薬学的組合せ |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9518085B2 (enExample) |
| EP (1) | EP2733149B9 (enExample) |
| JP (1) | JP6023803B2 (enExample) |
| KR (1) | KR101987978B1 (enExample) |
| CN (1) | CN103649106B (enExample) |
| AR (1) | AR087034A1 (enExample) |
| AU (1) | AU2012280776B2 (enExample) |
| BR (1) | BR112013033970B1 (enExample) |
| CA (1) | CA2838496C (enExample) |
| CU (1) | CU23963B1 (enExample) |
| DK (1) | DK2733149T3 (enExample) |
| ES (1) | ES2601887T3 (enExample) |
| IN (1) | IN2014CN00510A (enExample) |
| MX (1) | MX345534B (enExample) |
| RU (1) | RU2569302C2 (enExample) |
| SI (1) | SI2733149T1 (enExample) |
| WO (1) | WO2013004203A1 (enExample) |
| ZA (1) | ZA201309554B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3013355B1 (en) * | 2013-06-25 | 2019-08-07 | ICM - Institut du Cerveau et da la Moelle Epinière | Il-2 for use in treating alzheimer disease and related disorders |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| RU2613765C1 (ru) * | 2016-01-26 | 2017-03-21 | Федеральное государственное автономное образовательное учреждение высшего образования "Северо-Восточный федеральный университет им. М.К.Аммосова" | Способ лечения спиноцеребеллярной атаксии |
| CN108752445B (zh) * | 2018-06-20 | 2021-04-30 | 广东药科大学 | 一种螺旋藻蛋白的制备工艺及其神经保护用途 |
| KR102152407B1 (ko) * | 2019-02-26 | 2020-09-07 | (주)나우코스 | 스피루리나에서 유래한 파이코시아노블린 및 이의 유도체를 유효성분으로 포함하는 화장료 조성물 |
| KR20210091664A (ko) | 2020-01-14 | 2021-07-22 | 경북대학교 산학협력단 | 중간엽 줄기세포 유래 단백질을 포함하는 소뇌성운동실조증의 치료 예후를 예측하기 위한 바이오마커, 및 이를 이용한 소뇌성운동실조증의 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5709855A (en) | 1995-09-22 | 1998-01-20 | Bockow; Barry I. | Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain |
| US20040110938A1 (en) * | 2000-02-24 | 2004-06-10 | Parekh Rajesh Bhikhu | Proteins, genes and their use for diagnosis and treatment of schizophrenia |
| US7025965B1 (en) * | 2003-02-12 | 2006-04-11 | Pharma Chemie, Inc. | Method of use and dosage composition of bluegreen algae extract for inflammation in animals |
| US7534423B2 (en) * | 2003-03-28 | 2009-05-19 | Faron Pharmaceuticals Oy | Method for inducing an elevated level of adenosine in an individual |
| CU23581A1 (es) * | 2005-10-28 | 2010-10-30 | Ct Ingenieria Genetica Biotech | Interferon alfa y c-ficocianina para el tratamiento de enfermedades autoinmunes, alérgicas y cáncer |
| DK2046354T3 (da) * | 2006-06-27 | 2011-10-31 | Nutratec S R L | Aphanizomenon Flos Aquae-fremstilling, ekstrakter og oprensede bestanddele deraf til behandling af neurologiske, neurodegenerative og humørforstyrrelser |
| US8709434B2 (en) * | 2006-11-13 | 2014-04-29 | Pcb Associates, Inc. | Compositions for inhibiting NADPH oxidase activity |
-
2011
- 2011-07-01 CU CU2011000146A patent/CU23963B1/es unknown
-
2012
- 2012-06-29 AU AU2012280776A patent/AU2012280776B2/en not_active Ceased
- 2012-06-29 US US14/127,369 patent/US9518085B2/en active Active
- 2012-06-29 JP JP2014517444A patent/JP6023803B2/ja not_active Expired - Fee Related
- 2012-06-29 DK DK12743356.3T patent/DK2733149T3/en active
- 2012-06-29 RU RU2014103246/04A patent/RU2569302C2/ru active
- 2012-06-29 MX MX2013015206A patent/MX345534B/es active IP Right Grant
- 2012-06-29 IN IN510CHN2014 patent/IN2014CN00510A/en unknown
- 2012-06-29 WO PCT/CU2012/000003 patent/WO2013004203A1/es not_active Ceased
- 2012-06-29 CN CN201280032375.5A patent/CN103649106B/zh not_active Expired - Fee Related
- 2012-06-29 SI SI201230756A patent/SI2733149T1/sl unknown
- 2012-06-29 BR BR112013033970-5A patent/BR112013033970B1/pt not_active IP Right Cessation
- 2012-06-29 CA CA2838496A patent/CA2838496C/en active Active
- 2012-06-29 KR KR1020147002552A patent/KR101987978B1/ko not_active Expired - Fee Related
- 2012-06-29 ES ES12743356.3T patent/ES2601887T3/es active Active
- 2012-06-29 EP EP12743356.3A patent/EP2733149B9/en active Active
- 2012-07-02 AR ARP120102397A patent/AR087034A1/es unknown
-
2013
- 2013-12-18 ZA ZA2013/09554A patent/ZA201309554B/en unknown
-
2016
- 2016-11-10 US US15/348,451 patent/US20170119733A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014103246A (ru) | Соединения и фармацевтические комбинации для лечения нейродегенеративных и ишемических болезней мозга | |
| KR102375262B9 (en) | GLP-1 Pharmaceutical composition comprising sustained release-microsphere comprising GLP-1 Analogue or pharmaceutically acceptable salt thereof | |
| JP2020023567A5 (enExample) | ||
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP2012115277A5 (enExample) | ||
| JP2015513544A5 (enExample) | ||
| JP2019513752A5 (enExample) | ||
| WO2012012600A3 (en) | Peptide compounds for regulating the complement system | |
| JP2016517421A5 (enExample) | ||
| RU2010111114A (ru) | Нейропротективное действие с применением nap-подобных и sal-подобных пептидных миметиков | |
| JP2013520405A5 (enExample) | ||
| JP2014510101A5 (enExample) | ||
| JP2013518090A5 (enExample) | ||
| FI3712264T3 (fi) | Kystationiini-beta-syntaasientsyymi homokystinurian hoitoon | |
| JP2013544245A5 (ja) | ネプリライシンの発現および活性を増大させるための医薬組成物 | |
| JP2017501999A5 (enExample) | ||
| JP2010509345A5 (enExample) | ||
| WO2008057609A4 (en) | Methods of treating neuronal disorders using mntf peptides and analogs thereof | |
| JP2018532763A5 (enExample) | ||
| JP2013535965A5 (enExample) | ||
| JP2015514771A5 (enExample) | ||
| EP4219534A3 (en) | Methods for treatment of and prophylaxis against inflammatory disorders | |
| KR102084341B1 (ko) | 짧은 합성 펩티드 및 그의 용도 | |
| JP2021518392A5 (enExample) | ||
| HRP20250746T1 (hr) | Peptidni spojevi i njihova terapijska upotreba |